BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markham A. Tavaborole: first global approval. Drugs. 2014;74:1555-1558. [PMID: 25118637 DOI: 10.1007/s40265-014-0276-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Borys KM, Wieczorek D, Pecura K, Lipok J, Adamczyk-Woźniak A. Antifungal activity and tautomeric cyclization equilibria of formylphenylboronic acids. Bioorg Chem 2019;91:103081. [PMID: 31445482 DOI: 10.1016/j.bioorg.2019.103081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kim A, Suzuki Y, Nagasaki Y. Molecular design of a high-performance polymeric carrier for delivery of a variety of boronic acid-containing drugs. Acta Biomater 2021;121:554-65. [PMID: 33321218 DOI: 10.1016/j.actbio.2020.12.015] [Reference Citation Analysis]
3 Natsutani I, Iwata R, Yamai Y, Ishida K, Nagaoka Y, Sumiyoshi T. Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds. Chem Biol Drug Des 2019;93:657-65. [DOI: 10.1111/cbdd.13496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
4 Shamsizadeh F, Ansari S, Zarei Mahmoudabadi A, Hubka V, Čmoková A, Guillot J, Rafiei A, Zomorodian K, Nouripour-Sisakht S, Diba K, Mohammadi T, Zarrinfar H, Rezaei-Matehkolaei A. In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin. Mycoses 2021. [PMID: 33864711 DOI: 10.1111/myc.13287] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gupta AK, Daigle D, Foley KA. Network Meta-Analysis of Onychomycosis Treatments. Skin Appendage Disord 2015;1:74-81. [PMID: 27170937 DOI: 10.1159/000433473] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
6 Poulakos M, Grace Y, Machin JD, Dorval E. Efinaconazole and Tavaborole. J Pharm Pract 2017;30:245-55. [PMID: 26873506 DOI: 10.1177/0897190016630904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Piraccini BM, Alessandrini A. Onychomycosis: A Review. J Fungi (Basel) 2015;1:30-43. [PMID: 29376897 DOI: 10.3390/jof1010030] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
8 Walker AL, Denis A, Bingham RP, Bouillot A, Edgar EV, Ferrie A, Holmes DS, Laroze A, Liddle J, Fouchet M, Moquette A, Nassau P, Pearce AC, Polyakova O, Smith KJ, Thomas P, Thorpe JH, Trottet L, Wang Y, Hovnanian A. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorganic & Medicinal Chemistry Letters 2019;29:126675. [DOI: 10.1016/j.bmcl.2019.126675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Kerai LV, Hilton S, Murdan S. UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases. International Journal of Pharmaceutics 2015;492:177-90. [DOI: 10.1016/j.ijpharm.2015.07.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
10 Kuplińska A, Rząd K. Molecular targets for antifungals in amino acid and protein biosynthetic pathways. Amino Acids 2021;53:961-91. [PMID: 34081205 DOI: 10.1007/s00726-021-03007-6] [Reference Citation Analysis]
11 Jinna S, Finch J. Spotlight on tavaborole for the treatment of onychomycosis. Drug Des Devel Ther 2015;9:6185-90. [PMID: 26640371 DOI: 10.2147/DDDT.S81944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
12 Mazzantini D, Celandroni F, Calvigioni M, Lupetti A, Ghelardi E. In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum. Antimicrob Agents Chemother 2021;65:e02324-20. [PMID: 33468466 DOI: 10.1128/AAC.02324-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Murugan K, Chinnapattu M, Nawaz Khan F, Iyer PS. Synthesis of novel benzoxaborinin-4-ones and its application in indolin-2-ones synthesis using a Suzuki–Miyaura reaction protocol. RSC Adv 2015;5:36902-5. [DOI: 10.1039/c5ra05755h] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Gupta AK, Studholme C. Novel investigational therapies for onychomycosis: an update. Expert Opin Investig Drugs 2016;25:297-305. [PMID: 26765142 DOI: 10.1517/13543784.2016.1142529] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
15 Wright JS, Scott PJH, Steel PG. Iridium-Catalysed C-H Borylation of Heteroarenes: Balancing Steric and Electronic Regiocontrol. Angew Chem Int Ed Engl 2021;60:2796-821. [PMID: 32202024 DOI: 10.1002/anie.202001520] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
16 Wright JS, Scott PJH, Steel PG. Iridium‐katalysierte C‐H‐Borylierung von Heteroarenen: Eine Balance zwischen sterischer and elektronischer Regiokontrolle. Angew Chem 2021;133:2830-56. [DOI: 10.1002/ange.202001520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
17 Yang F, Zhu M, Zhang J, Zhou H. Synthesis of biologically active boron-containing compounds. Medchemcomm 2018;9:201-11. [PMID: 30108914 DOI: 10.1039/c7md00552k] [Cited by in Crossref: 53] [Cited by in F6Publishing: 6] [Article Influence: 13.3] [Reference Citation Analysis]
18 Machado Á, Torres T. Guselkumab for the Treatment of Psoriasis. BioDrugs 2018;32:119-28. [PMID: 29470778 DOI: 10.1007/s40259-018-0265-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
19 Plescia J, Moitessier N. Design and discovery of boronic acid drugs. European Journal of Medicinal Chemistry 2020;195:112270. [DOI: 10.1016/j.ejmech.2020.112270] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 31.0] [Reference Citation Analysis]
20 Steketee PC, Vincent IM, Achcar F, Giordani F, Kim DH, Creek DJ, Freund Y, Jacobs R, Rattigan K, Horn D, Field MC, MacLeod A, Barrett MP. Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei. PLoS Negl Trop Dis 2018;12:e0006450. [PMID: 29758036 DOI: 10.1371/journal.pntd.0006450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]